Multiple Sclerosis Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

World MS Day 2026: Earlier Diagnosis and New Treatment Options in Multiple Sclerosis

Genentech’s Fenebrutinib Yields Positive Results in Phase III MS Trial

February 18, 2026

A Modern Approach to Multiple Sclerosis Trials Applying Innovative Digital Endpoint Solutions

Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies

World MS Day 2025: Top Innovations in Diagnosis and Treatment

Apimeds Pharmaceuticals US IPO Backs Bee Venom for Osteoarthritis Treatment

MS Drugs Copaxone and Glatopa Get FDA Boxed Warnings for Anaphylaxis

January 24, 2025

Working Faster Than the Speed of ALS to Transform Neurodegenerative Disease Research

September 30, 2024

Ocrevus Zunovo Subcutaneous Solution for MS Gains FDA Approval

September 16, 2024

Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes

September 17, 2024

Life Science Podcast

Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho

World MS Day 2024 and Ongoing Clinical Trials for Multiple Sclerosis

Building Connections on World MS Day 2023

Briumvi is FDA Approved for Relapsing Forms of Multiple Sclerosis

January 6, 2023

Life Science News

Harvard Study Shows Epstein-Barr Virus Could Cause Multiple Sclerosis

January 25, 2022

Caffeine Consumption in Pregnancy + Portable Neuromodulation Stimulator for MS – Xtalks Life Science Podcast Ep. 4

Next Page »